About this trial
Eligible participants will first undergo a 1-week home blood pressure diary and 24-hour ambulatory blood pressure assessment. After a confirmed diagnosis of hypertension, etiological subtyping will be performed. Based on the blood pressure evaluation results and etiological classification, the most appropriate antihypertensive medication will be selected. Simultaneously, a personalized lifestyle prescription will be provided according to the patient's individual circumstances. Following medication initiation, participants will continue to monitor their blood pressure through home diaries. Monthly evaluations will be conducted, and if blood pressure fails to reach the target value, medication adjustments will be made based on the blood pressure diary until target levels are achieved. This regimen will be maintained long-term.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18-65 years.
Diagnosed primary hypertension (systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg).
signed informed consent.
Disqualifiers
Secondary hypertension or arrhythmias affecting blood pressure accuracy (e.g., atrial fibrillation).
Comorbidities such as diabetes, chronic kidney disease (eGFR < 30 mL/min/1.73m²), coronary artery disease, heart failure, or serious valvular heart disease.
History of stroke or myocardial infarction.
Pregnancy, breastfeeding, or planning to become pregnant.
Trial design
Single group
Treatments tested in this trial
Etiological Classification and Digital Intervention
Other interventionEligible participants will first undergo a 1-week home blood pressure diary and 24-hour ambulatory blood pressure assessment. After a confirmed diagnosis of hypertension, etiological subtyping will be performed. Based on the blood pressure evaluation results and etiological classification, the most appropriate antihypertensive medication will be selected. Simultaneously, a personalized lifestyle prescription will be provided according to the patient's individual circumstances. Following medication initiation, participants will continue to monitor their blood pressure through home diaries. Monthly evaluations will be conducted, and if blood pressure fails to reach the target value, medication adjustments will be made based on the blood pressure diary until target levels are achieved. This regimen will be maintained long-term.
Treatment groups
Trial outcomes
Primary outcomes
Changes in Blood Pressure Recorded in a 1-Week Home Blood Pressure Diary
Changes in blood pressure recorded (SBP/DBP) in a 1-week home blood pressure diary from baseline to 3 months.
Secondary outcomes
Change in 24-hour Ambulatory Blood Pressure Monitoring
Change in 24-hour ambulatory blood pressure monitoring (daytime, nighttime, and overall SBP/DBP) at 1/2 /3 months.
Change in Home Blood Pressure Monitoring
Change in home blood pressure monitoring (SBP/DBP) at 1/2months.
Control Rate
Proportion of patients achieving target blood pressure at 3 months.
Drug adjustment times
The total number of times to adjust blood pressure medication in 3 months
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: